Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice.
腸道胰高血糖素樣肽-1:與1型糖尿病小鼠低血糖反應調節失常相關的新角色。
World J Diabetes 2024-08-28
Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
葡萄糖素作用於 GLP-1 受體有助於葡萄糖素受體拮抗劑誘導的糖尿病小鼠胰島β細胞再生。
Diabetes 2023-05-14
GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion.
GLP-1代謝物GLP-1(9-36)是老鼠和人類胰島素胰高血糖素分泌的全身抑制劑。
Diabetologia 2024-03-13
GLP-1 in patients with myocardial infarction complicated by cardiogenic shock-an IABP-SHOCK II-substudy.
心肌梗死併發心源性休克患者中 GLP-1 的研究 - IABP-SHOCK II 子研究。
Clin Res Cardiol 2024-01-03
Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery.
內源性胰高血糖素樣肽-1對患有和未患肥胖手術的人類在進餐後對低血糖的反調節反應的差異影響。
Diabetes Obes Metab 2024-05-10
Use of continuous glucose monitoring when initiating glucagon-like peptide-1 receptor agonist therapy in insulin-treated diabetes.
在接受胰島素治療的糖尿病患者中啟動胰高血糖素樣肽-1受體激動劑療法時持續血糖監測的使用。
Diabetes Obes Metab 2024-08-28